Skip to main content

Table 2 Changes in parameters related to CKD-MBD and atherosclerosis

From: Comparison of the effects of lanthanum carbonate and calcium carbonate on the progression of cardiac valvular calcification after initiation of hemodialysis

 LC (n = 24)CC (n = 26)
0 M18 M0 M18 M
cCa (mg/dL)8.5 ± 0.88.8 ± 0.88.4 ± 0.89.2 ± 0.6
P (mg/dL)6.0 ± 1.35.5 ± 1.25.9 ± 1.55.1 ± 1.4
iPTH (pg/mL)216.0 (128.5–531.8)155.0 (69.1–194.5)*281.0 (217.8–422.5)98.5 (38.0–192.8)
iFGF23 (pg/mL)737.5 (456.8–1875.9)2430.5 (750.8–7560.8)*588.1 (264.5–1880.6)2630.4 (747.1–13,741.8)
LDL-C (mg/dL)86.0 ± 37.284.4 ± 24.486.8 ± 30.673.6 ± 23.1
PS6.7 (3.8–14.1)9.2 (4.8–18.0)*5.6 (1.3–11.6)7.0 (3.3–12.8)
  1. Values are presented as the median and interquartile or mean ± SD
  2. LC lanthanum carbonate group, CC calcium carbonate, cCa corrected calcium, P phosphorus, iPTH intact parathyroid hormone, iFGF23 intact fibroblast growth factor 23, LDL-C low density lipoprotein cholesterol, PS plaque score
  3. *LC at 0 M versus LC at 18 M, p < 0.05; CC at 0 M versus CC at 18 M, p < 0.05